Back to companies
PORTFOLIO
Haya Therapeutics
HAYA Therapeutics is a precision medicines company developing programmable therapeutics that target regulatory RNAs derived from the dark genome – a cell information processing unit. The goal is to reprogram pathological cell states for the treatment of rare, common, chronic and aging-related diseases, including cardiovascular disease and cancer.
Milestones
Founded: 2019 Invested: 2025
Leadership Team
Samir Ounzain Daniel Blessing
HQ
Lausanne, Switzerland
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.
